GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vireo Growth Inc (FRA:0ZF) » Definitions » EV-to-EBITDA

Vireo Growth (FRA:0ZF) EV-to-EBITDA : 9.88 (As of Jan. 18, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Vireo Growth EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vireo Growth's enterprise value is €238.77 Mil. Vireo Growth's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was €24.16 Mil. Therefore, Vireo Growth's EV-to-EBITDA for today is 9.88.

The historical rank and industry rank for Vireo Growth's EV-to-EBITDA or its related term are showing as below:

FRA:0ZF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -58.83   Med: -1.31   Max: 6051.18
Current: 9.92

During the past 13 years, the highest EV-to-EBITDA of Vireo Growth was 6051.18. The lowest was -58.83. And the median was -1.31.

FRA:0ZF's EV-to-EBITDA is ranked better than
67.55% of 718 companies
in the Drug Manufacturers industry
Industry Median: 13.655 vs FRA:0ZF: 9.92

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-01-18), Vireo Growth's stock price is €0.464. Vireo Growth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.096. Therefore, Vireo Growth's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Vireo Growth EV-to-EBITDA Historical Data

The historical data trend for Vireo Growth's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vireo Growth EV-to-EBITDA Chart

Vireo Growth Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.34 -27.15 -20.48 -14.52 5.78

Vireo Growth Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.12 5.78 5.98 5.41 6.89

Competitive Comparison of Vireo Growth's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Vireo Growth's EV-to-EBITDA falls into.



Vireo Growth EV-to-EBITDA Calculation

Vireo Growth's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=238.767/24.155
=9.88

Vireo Growth's current Enterprise Value is €238.77 Mil.
Vireo Growth's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €24.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vireo Growth  (FRA:0ZF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Vireo Growth's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.464/-0.096
=At Loss

Vireo Growth's share price for today is €0.464.
Vireo Growth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.096.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Vireo Growth EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Vireo Growth's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Vireo Growth Business Description

Traded in Other Exchanges
Address
207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Inc is a cannabis company whose mission is to provide safe access, quality products, and value to its customers while supporting its local communities through active participation and restorative justice programs.

Vireo Growth Headlines

No Headlines